Biomarkers /
CDKN1A
Overview
Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A) is a gene that encodes a protein that functions as a potent cyclin-dependent kinase inhibitor. The protein inhibits cyclin/CDK2 or cyclin/CDK4 complexes. Missense mutations, nonsense mutations, silent mutations, and frameshift deletions and insertions are observed in cancers such as intestinal cancer, liver cancer, and stomach cancer.
Clinical Trials
Significance of CDKN1A in Diseases
References
1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.